A detailed history of Fifth Third Bancorp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fifth Third Bancorp holds 44,120 shares of BDX stock, worth $10.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
44,120
Previous 42,552 3.68%
Holding current value
$10.7 Million
Previous $10.3 Million 2.44%
% of portfolio
0.04%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

BUY
$220.02 - $243.75 $344,991 - $382,200
1,568 Added 3.68%
44,120 $10 Million
Q3 2024

Oct 17, 2024

SELL
$221.47 - $242.41 $155,250 - $169,929
-701 Reduced 1.62%
42,552 $10.3 Million
Q2 2024

Jul 22, 2024

SELL
$225.07 - $246.17 $677,685 - $741,217
-3,011 Reduced 6.51%
43,253 $10.1 Million
Q1 2024

Apr 23, 2024

BUY
$233.45 - $247.73 $2.01 Million - $2.13 Million
8,608 Added 22.86%
46,264 $11.4 Million
Q4 2023

Jan 19, 2024

BUY
$232.24 - $267.23 $110,081 - $126,667
474 Added 1.27%
37,656 $9.18 Million
Q3 2023

Oct 31, 2023

BUY
$254.9 - $283.59 $315,566 - $351,084
1,238 Added 3.44%
37,182 $9.61 Million
Q2 2023

Jul 25, 2023

BUY
$238.39 - $265.32 $217,411 - $241,971
912 Added 2.6%
35,944 $9.49 Million
Q1 2023

Apr 24, 2023

SELL
$229.71 - $259.35 $251,991 - $284,506
-1,097 Reduced 3.04%
35,032 $8.67 Million
Q4 2022

Jan 25, 2023

SELL
$218.29 - $256.91 $740,657 - $871,695
-3,393 Reduced 8.59%
36,129 $0
Q3 2022

Oct 25, 2022

SELL
$51.03 - $264.23 $70,982 - $367,543
-1,391 Reduced 3.4%
39,522 $8.81 Million
Q2 2022

Aug 04, 2022

BUY
$234.74 - $275.42 $292,251 - $342,897
1,245 Added 3.14%
40,913 $10.1 Million
Q1 2022

Apr 19, 2022

BUY
$243.64 - $270.48 $230,727 - $256,144
947 Added 2.45%
39,668 $10.6 Million
Q4 2021

Feb 01, 2022

BUY
$230.08 - $250.94 $392,976 - $428,605
1,708 Added 4.61%
38,721 $9.74 Million
Q3 2021

Oct 15, 2021

BUY
$232.72 - $256.47 $73,074 - $80,531
314 Added 0.86%
37,013 $9.1 Million
Q2 2021

Aug 06, 2021

SELL
$232.65 - $254.58 $210,315 - $230,140
-904 Reduced 2.4%
36,699 $8.93 Million
Q1 2021

May 07, 2021

SELL
$232.09 - $256.88 $81,927 - $90,678
-353 Reduced 0.93%
37,603 $9.14 Million
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $156,675 - $173,633
706 Added 1.9%
37,956 $9.5 Million
Q3 2020

Nov 09, 2020

SELL
$215.77 - $276.76 $414,925 - $532,209
-1,923 Reduced 4.91%
37,250 $8.67 Million
Q2 2020

Aug 05, 2020

SELL
$219.9 - $263.41 $130,180 - $155,938
-592 Reduced 1.49%
39,173 $9.37 Million
Q1 2020

May 05, 2020

BUY
$195.69 - $279.01 $140,701 - $200,608
719 Added 1.84%
39,765 $9.14 Million
Q4 2019

Feb 14, 2020

SELL
$236.45 - $266.82 $271,444 - $306,309
-1,148 Reduced 2.86%
39,046 $10.6 Million
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $90,156 - $100,127
391 Added 0.98%
40,194 $10.2 Million
Q2 2019

Aug 07, 2019

BUY
$217.4 - $246.08 $224,139 - $253,708
1,031 Added 2.66%
39,803 $10 Million
Q1 2019

May 14, 2019

BUY
$206.05 - $248.17 $76,238 - $91,822
370 Added 0.96%
38,772 $9.68 Million
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $29,276 - $36,883
143 Added 0.37%
38,402 $8.65 Million
Q3 2018

Nov 14, 2018

SELL
$233.07 - $256.0 $294,367 - $323,328
-1,263 Reduced 3.2%
38,259 $9.99 Million
Q2 2018

Aug 14, 2018

BUY
$208.1 - $233.85 $151,080 - $169,775
726 Added 1.87%
39,522 $9.47 Million
Q1 2018

May 15, 2018

BUY
$205.46 - $240.27 $252,510 - $295,291
1,229 Added 3.27%
38,796 $8.41 Million
Q4 2017

Feb 14, 2018

SELL
$189.0 - $222.64 $71,064 - $83,712
-376 Reduced 0.99%
37,567 $8.04 Million
Q3 2017

Nov 14, 2017

SELL
$186.89 - $198.9 $202,962 - $216,005
-1,086 Reduced 2.78%
37,943 $7.44 Million
Q2 2017

Aug 11, 2017

BUY
N/A
39,029
39,029 $7.62 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $69.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.